Tianjin, China – August 9, 2022 – Tianjin Era Biology Technology Co., Ltd was award as National Professionalization, Refinement, Characteristic and Novelty “Little Giant” by National Ministry of In...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
Era Biology will host global live webinar at 12th July. Due to the fact that WHO has declared that antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. ...
Genobio Successfully Registered CE-IVDR for Its Instruments
Tianjin, China – October 7, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and...
(1,3)-β-D-Glucan is a component of the cell walls of many fungal organisms. Scientists investigate the feasibility of the BG assay and its contribution to early diagnosis of different types of inva...
Invasive candidiasis is a frequent life-threatening complication in critically ill patients. Early diagnosis followed by prompt treatment aimed at improving outcome by minimizing unnecessary antifu...